Janney Notes Strong Nucynta Rx Trends for March; Affirms DepoMed (DEPO) at 'Buy'

Go back to Janney Notes Strong Nucynta Rx Trends for March; Affirms DepoMed (DEPO) at 'Buy'
DepoMed, Inc. (NASDAQ: DEPO) Delayed: 7.30 --0 (-0%)
Previous Close $7.30    52 Week High $27.02 
Open $3.47    52 Week Low $12.25 
Day High $7.30    P/E N/A 
Day Low $7.30    EPS $-0.04 
Volume